WSJ
19 Aug 2026, 20:17 UTC · 3h ago
Bond Yields Dive After Treasury Increases Buybacks
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
WSJ
19 Aug 2026, 20:17 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Moderna and Merck shares surged following positive results from their mRNA cancer vaccine trials. — Positive clinical data for a high-addressable market like cancer typically drives significant valuation increases for biotech and pharma companies.
+0.80Which stocks this story touches
The company's stock surged following positive mRNA cancer vaccine results.
The company's stock surged following positive mRNA cancer vaccine results.
Continue reading
6 related stories
Top 1 mover · tap to explore
[mutual] Moderna and Merck are collaborating on mRNA cancer vaccines.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
13h ago
